Associate Professor of Radiation Oncology and Molecular Radiation Sciences, Associate Professor of Oncology, Associate Professor of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine
Radiation Oncology
Dr. Harry Quon, MD
|
|
Give Review
Doctor Harry Quon, MD works in the field of Radiation Oncology. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Harry Quon is also a published doctor. He has 71 paper published. The most recent paper is: The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.
- Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors.
- Disease-free survival after salvage therapy for recurrent oropharyngeal squamous cell carcinoma.
- Short- and long-term outcomes of laryngeal cancer care in the elderly.
- Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative On...
- Late Consequential Surgical Bed Soft Tissue Necrosis in Advanced Oropharyngeal Squamous Cell Carcinomas Treated With Transoral Robotic Surgery and Postoperative Radiat...
- Feasibility of rapid discharge after transoral robotic surgery of the oropharynx.
- ACR Appropriateness Criteria® thyroid carcinoma.
- Erratum to: Effect of Gabapentin on Swallowing During and After Chemoradiation for Oropharyngeal Squamous Cell Cancer.
- Effect of Gabapentin on Swallowing During and After Chemoradiation for Oropharyngeal Squamous Cell Cancer.
- PET/CT Imaging and Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Cancer: Evolving Clinical Imaging Paradigm.
- Transcervical ultrasonography is feasible to visualize and evaluate base of tongue cancers.
- The effect of transoral robotic surgery on short-term outcomes and cost of care after oropharyngeal cancer surgery.
- Treatment, survival, and costs of laryngeal cancer care in the elderly.
- Radiation dose to the floor of mouth muscles predicts swallowing complications following chemoradiation in oropharyngeal squamous cell carcinoma.
- FDG PET/CT Imaging of Oropharyngeal Squamous Cell Carcinoma: Characteristics of Human Papillomavirus-Positive and -Negative Tumors.
- Swallowing outcomes in patients with oropharyngeal cancer undergoing organ preservation treatment.
- ACR Appropriateness Criteria(®) Treatment of Stage 1 T1 Glottic Cancer.
- Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck.
- Reply, Contralateral irradiation for T(limited) N2bM0 lateralized tonsil cancer.
- Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom?
- Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.
- Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7...
- FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.
- Sweet syndrome in a field of radiation therapy.
- Treatment deintensification strategies for HPV-associated head and neck carcinomas.
- Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas.
- Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16(INK4a)on treatment outcomes.
- Assessment of tumor angiogenesis as a prognostic factor of survival in patients with oligodendroglioma.
- The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer.
- Potential molecular prognostic markers in head and neck squamous cell carcinomas.
- Injection augmentation of arytenoids after partial laryngectomy: case series.
- Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.
- Treatment planning dosimetric parameters for a (90)Y coil source used in intravascular brachytherapy.
- Ytterbium-169: a promising new radionuclide for intravascular brachytherapy.
- Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.
- Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy.
- Transoral robotic photodynamic therapy for the oropharynx.
- Interference with the Jaffé method for creatinine following 5-aminolevulinic acid administration.
- Transoral robotic surgery for advanced oropharyngeal carcinoma.
- Transoral robotic surgery for parapharyngeal space tumors.
- Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: an intergr...
- Postradiotherapy neck dissection: an obsolete treatment paradigm?
- Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy.
- Treatment of metastatic epidural spinal cord compression: the Goldilocks principle.
- ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck.
- ACR Appropriateness Criteria(®) Retreatment of Recurrent Head and Neck Cancer After Prior Definitive Radiation Expert Panel on Radiation Oncology-Head and N...
- Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma.
- Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function.
- Transoral robotic surgery and human papillomavirus status: Oncologic results.
- Postoperative adjuvant therapy after transoral robotic resection for oropharyngeal carcinomas: rationale and current treatment approach.
- Targeted laryngeal photodynamic therapy with a balloon diffusing light source.
- Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania tran...
- Gabapentin for the treatment of pain syndrome related to radiation-induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapy.
- ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas.
- Proton and phosphorous MR spectroscopy in squamous cell carcinomas of the head and neck.
- Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy.
- Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT.
- Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes.
- Transoral robotic surgery: does the ends justify the means?
- Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.
- Transoral robotic surgery: radical tonsillectomy.
- Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer.
- Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast-enhanced MRI data in squamous cell carcinoma of the head and neck.
- Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome.
- Noninvasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study.
- Eccrine porocarcinoma of the nose: case report and review of world literature.
- Brachytherapy in pediatric oncology.
- Brachytherapy in the treatment of head and neck cancer.
- High beta and electron dose from 192Ir: implications for "gamma" intravascular brachytherapy.
Schools
University Of Toronto Faculty Of Medicine
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Select
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Preferred PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- Golden Rule
- GEHA
- Choice Care PPO
- Kaiser Permanente
- Mail Handlers Benefit Plan (MHBP)
- MedHealthInsurance
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Options PPO
- United Healthcare
- Wells Fargo Insurance
Awards
- CMS Meaningful Use Stage 1 Certification
Hospital
-
Howard County General Hospital -
Johns Hopkins Hospital -
Johns Hopkins Bayview Medical Center
Drug Facts
| NPI NUMBER | 1184654253 | |
| NPPES Provider LastName | QUON | |
| NPPES Provider FirstName | HARRY | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 70.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 22.86 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1184654253 |
| Last Name Of The Provider | QUON |
| First Name Of The Provider | HARRY |
| View All |
Similar Doctors
|
|
Dr. Franco M. Nichini, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Guttmann, MD |
|
|
Dr. Brian C. Baumann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark A. Hallman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Penny R. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Simeon James K. Yamoah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xinglei Shen, MD |
|
|
Dr. Gita Suneja, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John N. Lukens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Annemarie T. Fernandes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael N. Corradetti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angelica T. Montesano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard J. Torpie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary D. Kao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Glassburn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. Kolker, MD
This Doctor is OpenDoctor Recommended.
|